Question: Tumor-infiltrating lymphocyte (TIL) scoring protocols in solid tumors

FDA or EMA regulatory position on TIL scoring as companion diagnostic

Collecting findings

0/2 publication-ready

Findings metrics

—

total

—

verified

—

pending

—

rejected